Challenges with license agreements in the healthcare sector

Challenges with license agreements in the healthcare sector

The increasing use of in- and out-licensing agreements in the healthcare sector is influenced by various factors. These include the high development costs and risks of new drugs and technologies, the lack of internal expertise and the need to expand the product and patent portfolio.

For biotech and pharmaceutical companies, licensing agreements open up opportunities to gain access to innovative technologies and new markets while reducing financial and organizational risks. This is particularly important in order to remain competitive in a constantly changing industry.

In order to take full advantage of the benefits of in- and out-licensing, it is crucial to deal with the associated challenges.

Reasons for in- and out-licensing

In-licensing

  • Expansion of own portfolio and innovative strength
  • Risk minimization
  • Access to new markets

Out-licensing

  • Generating new revenue
  • Outsourcing part of your own activities
  • Sharing risks with partners

Our services

  • Valuation of the product or IP portfolio 
  • Legal and tax structuring of license deals 
  • Legal structuring and negotiation of license agreements  
  • Tax optimization and structuring of licensing relationships 
  • Development and optimization of license fees  
  • Financial reporting of license deals 
  • Cross-border structuring of IP strategies
Stephan Zuber

Stephan Zuber

Partner

Attorney-at-Law (Rechtsanwalt), Specialist Lawyer for Commercial and Corporate Law

What can we do for you?

Talk to us - without any obligation

Contact now